UrSure impacts PrEP adherence and retention
Channel: Science Animated
Date: 2020-02-24

UrSure, Inc., is an HIV prevention startup that makes diagnostic tests to measure and improve adherence for patients on PrEP for HIV prevention or medication for HIV treatment. We are collaborating with public health departments, researchers, and clinics to use our novel, lab-based urine test to help reduce HIV incidence across the US. After thousands of urine samples have been run, we’ve generated some real-world data that shows how UrSure has impacted adherence and retention for PrEP patients.
━━━━━━━━━━━━━━━━━━━━ 
Additional Information
────────────────────────────
http://www.ursureinc.com/ 
━━━━━━━━━━━━━━━━━━━━ 
Social Media
────────────────────────────
https://twitter.com/UrSureInc
━━━━━━━━━━━━━━━━━━━━ 
Science Animated
────────────────────────────
http://www.sciani.com/
https://twitter.com/Sci_Ani
https://www.facebook.com/scianimation/
━━━━━━━━━━━━━━━━━━━━
#UrSure
#HIV
#HIVPrep
━━━━━━━━━━━━━━━━━━━━